Finally, we show that Tg6F and ezetimibe prevent WD-induced increases in i) IFN-β, ii) cholesterol 25-hydroxylase (CH25H), and iii) 25-hydroxycholesterol (25-OHC) in jejunum. This evidence concerns the gene CH25H and Wilson disease.